Stock listing
ASX:CMP Compumedics Limited Share Price
Follow Compumedics Limited into a list and get an email when it puts out news.
Share price · ASX:CMP
$0.235 AUD 0.000 (0.0%)
Close on Nov 20, 2026
- Day range
- $0.225 – $0.235 AUDNov 20, 2026
- Volume
- 69,144 sharesNov 20, 2026
- Market cap
- $46.94M AUDAt the close on Nov 20, 2026 · price × 199.8M shares outstanding
- 52-week range
- $0.215 – $0.450 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $14,026 AUDMedian day 25,000 shares · 11 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:CMP · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.235 | 0.000 | 0.0% | $0.230 | $0.235 | $0.225 | 69,144 | |
| $0.235 | -0.005 | -2.1% | $0.235 | $0.235 | $0.235 | 74,147 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 0 | |
| $0.240 | +0.005 | +2.1% | $0.240 | $0.240 | $0.235 | 24,126 | |
| $0.235 | -0.010 | -4.1% | $0.240 | $0.240 | $0.235 | 19,300 | |
| $0.245 | +0.005 | +2.1% | $0.245 | $0.245 | $0.245 | 4,081 | |
| $0.240 | -0.010 | -4.0% | $0.245 | $0.245 | $0.240 | 13,700 | |
| $0.250 | +0.010 | +4.2% | $0.245 | $0.250 | $0.245 | 20,990 | |
| $0.240 | +0.005 | +2.1% | $0.245 | $0.250 | $0.240 | 135,000 | |
| $0.235 | -0.005 | -2.1% | $0.235 | $0.235 | $0.235 | 7,300 | |
| $0.240 | +0.010 | +4.3% | $0.235 | $0.240 | $0.230 | 40,588 | |
| $0.230 | 0.000 | 0.0% | $0.225 | $0.230 | $0.225 | 9,000 | |
| $0.230 | -0.005 | -2.1% | $0.230 | $0.230 | $0.230 | 2,460 | |
| $0.235 | +0.015 | +6.8% | $0.230 | $0.235 | $0.230 | 7,000 | |
| $0.220 | -0.020 | -8.3% | $0.230 | $0.230 | $0.220 | 194,352 | |
| $0.240 | +0.005 | +2.1% | $0.230 | $0.240 | $0.230 | 3,250 | |
| $0.235 | +0.005 | +2.2% | $0.235 | $0.235 | $0.235 | 3,823 | |
| $0.230 | 0.000 | 0.0% | $0.230 | $0.230 | $0.230 | 5,000 | |
| $0.230 | 0.000 | 0.0% | $0.230 | $0.230 | $0.230 | 0 | |
| $0.230 | -0.010 | -4.2% | $0.235 | $0.235 | $0.230 | 121,523 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 70,185 | |
| $0.240 | -0.010 | -4.0% | $0.250 | $0.250 | $0.240 | 6,350 | |
| $0.250 | +0.005 | +2.0% | $0.250 | $0.250 | $0.250 | 127,536 | |
| $0.245 | +0.005 | +2.1% | $0.245 | $0.245 | $0.245 | 4,040 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 0 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 0 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 0 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 0 | |
| $0.240 | -0.005 | -2.0% | $0.245 | $0.245 | $0.240 | 73,342 | |
| $0.245 | 0.000 | 0.0% | $0.245 | $0.245 | $0.245 | 0 | |
| $0.245 | -0.015 | -5.8% | $0.250 | $0.250 | $0.245 | 203,803 | |
| $0.260 | 0.000 | 0.0% | $0.260 | $0.260 | $0.260 | 0 | |
| $0.260 | 0.000 | 0.0% | $0.263 | $0.263 | $0.260 | 28,121 | |
| $0.260 | 0.000 | 0.0% | $0.260 | $0.260 | $0.255 | 42,345 | |
| $0.260 | 0.000 | 0.0% | $0.265 | $0.275 | $0.260 | 61,538 | |
| $0.260 | +0.020 | +8.3% | $0.250 | $0.260 | $0.250 | 123,300 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 5,000 | |
| $0.240 | +0.010 | +4.3% | $0.240 | $0.240 | $0.240 | 12,477 | |
| $0.230 | -0.010 | -4.2% | $0.230 | $0.230 | $0.230 | 25,000 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 0 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 11,398 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 85,058 | |
| $0.240 | 0.000 | 0.0% | $0.233 | $0.240 | $0.225 | 43,916 | |
| $0.240 | -0.010 | -4.0% | $0.230 | $0.250 | $0.230 | 107,207 | |
| $0.250 | +0.015 | +6.4% | $0.230 | $0.250 | $0.230 | 95,977 | |
| $0.235 | +0.005 | +2.2% | $0.235 | $0.235 | $0.235 | 4,255 | |
| $0.230 | -0.005 | -2.1% | $0.230 | $0.230 | $0.230 | 2,000 | |
| $0.235 | -0.040 | -14.5% | $0.240 | $0.240 | $0.235 | 46,583 | |
| $0.275 | 0.000 | 0.0% | $0.275 | $0.275 | $0.275 | 0 | |
| $0.275 | +0.050 | +22.2% | $0.230 | $0.275 | $0.225 | 67,296 | |
| $0.225 | -0.005 | -2.2% | $0.225 | $0.225 | $0.225 | 80,604 | |
| $0.230 | -0.003 | -1.1% | $0.230 | $0.240 | $0.230 | 90,333 | |
| $0.233 | -0.007 | -3.1% | $0.235 | $0.235 | $0.230 | 124,099 | |
| $0.240 | -0.010 | -4.0% | $0.240 | $0.240 | $0.240 | 2,000 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.250 | $0.250 | 2,268 | |
| $0.250 | +0.015 | +6.4% | $0.235 | $0.250 | $0.225 | 253,945 | |
| $0.235 | -0.040 | -14.5% | $0.235 | $0.235 | $0.235 | 516 | |
| $0.275 | +0.020 | +7.8% | $0.245 | $0.275 | $0.235 | 113,560 | |
| $0.255 | 0.000 | 0.0% | $0.240 | $0.270 | $0.240 | 27,736 | |
| $0.255 | 0.000 | 0.0% | $0.255 | $0.255 | $0.240 | 168,340 | |
| $0.255 | 0.000 | 0.0% | $0.255 | $0.255 | $0.255 | 47,100 | |
| $0.255 | -0.010 | -3.8% | $0.240 | $0.255 | $0.240 | 99,849 | |
| $0.265 | 0.000 | 0.0% | $0.265 | $0.265 | $0.265 | 0 | |
| $0.265 | 0.000 | 0.0% | $0.270 | $0.270 | $0.240 | 370,702 | |
| $0.265 | +0.030 | +12.8% | $0.240 | $0.270 | $0.240 | 343,812 | |
| $0.235 | +0.005 | +2.2% | $0.230 | $0.235 | $0.230 | 25,718 | |
| $0.230 | 0.000 | 0.0% | $0.235 | $0.235 | $0.225 | 37,326 |
- Ticker
- ASX:CMP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Nov 5, 2026
Appointment of Strategic Advisor
Latest deck · Nov 11, 2026
Investor Presentation (November 2026)
Investor deck · 18 slides
Latest news
Investor Update Nov-26
Nov 10, 2026
Closed $0.25 (+4.2%) on Nov 11, 2026
Appointment of Strategic Advisor
Nov 5, 2026
Closed $0.24 (+4.3%) on Nov 6, 2026
Appointment of Chief Financial Officer & Company Secretary
Oct 29, 2026
Closed $0.24 (+2.1%) on Oct 30, 2026
Results of Meeting
Oct 29, 2026
Closed $0.235 (+2.2%) on Oct 29, 2026
Chair's Address to Shareholders
Oct 28, 2026
Closed $0.235 (+2.2%) on Oct 29, 2026
Appendix 4G
Oct 1, 2026
Closed $0.24 (0.0%) on Oct 1, 2026
Corporate Governance Statement
Oct 1, 2026
Closed $0.24 (0.0%) on Oct 1, 2026
Proxy Form
Oct 1, 2026
Closed $0.24 (0.0%) on Oct 1, 2026
Notice of Annual General Meeting
Oct 1, 2026
Closed $0.24 (0.0%) on Oct 1, 2026
Investor Presentation
Sep 29, 2026
Closed $0.24 (+4.3%) on Sep 30, 2026
Compumedics Limited on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 18 in the last 12 months · 138 in all · newest Nov 10, 2026 · oldest 2016
- Decks
- 57 decks · latest Nov 11, 2026
Valuation
EV/sales 1.1× against a median of 1.0×: 7th lowest of 11 Medical devices & supplies companies shown. Statements: Year to Jun 30, 2025 · price Nov 20, 2026
- Enterprise value
- $58.13M AUD
- P/E
- Loss
- EV/sales
- 1.1×
- EV/EBITDA
- 19.6×
- Price/book
- 2.1×
- Gross margin
- 60.7%
- Operating margin
- 1.4%
- Net margin
- −2.5%
- Debt to equity
- 0.6×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Compumedics Limited · ASX:CMP | US$31.07M | US$38.48M | n/a | 1.1× | 19.6× | 2.1× | −2.5% | 0.6× | n/a |
| RecensMedical, Inc. · KRX:394420 | US$32.60M | US$23.79M | n/a | 4.9× | n/a | 2.2× | −169.4% | 0.1× | n/a |
| Myomo Inc. · AMEX:MYO | US$32.52M | US$32.23M | n/a | 0.7× | n/a | 11.8× | −33.1% | 4.2× | 2.25 |
| Meditera Tibbi Malzeme Sanayi ve Ticaret A.S. · BIST:MEDTR | US$32.29M | US$22.70M | 94.9× | 0.4× | 4.0× | 0.5× | 0.6% | 0.0× | n/a |
| OssDsign AB · OMXSTO:OSSD | US$32.24M | US$18.81M | n/a | 1.2× | n/a | 1.2× | −32.8% | 0.0× | n/a |
| PuriBlood Medical Co.,Ltd. · TPEX:6847 | US$31.47M | US$30.71M | n/a | 12.3× | n/a | 9.5× | −47.4% | 0.1× | n/a |
| Laseroptek Co., Ltd. · KRX:199550 | US$31.29M | US$18.72M | n/a | 0.8× | n/a | 1.4× | −22.5% | 0.0× | n/a |
| TELA Bio, Inc. · NASDAQ:TELA | US$31.11M | US$64.75M | n/a | 0.8× | n/a | n/a | −53.6% | n/a | 1.47 |
| Perfect Medical Industry Co., Ltd. · TPEX:6543 | US$30.55M | US$26.16M | 18.6× | 1.1× | 7.3× | 1.2× | 7.0% | 0.1× | n/a |
| Bioretec Ltd. · OMXHEX:BRETEC | US$30.33M | US$17.14M | n/a | 4.4× | n/a | 1.5× | −269.3% | 0.0× | n/a |
| Genoray Co., Ltd. · KRX:122310 | US$29.93M | US$17.56M | 15.4× | 0.2× | 3.4× | 0.5× | 2.4% | 0.0× | n/a |
| Median of the others | US$31.38M | US$23.24M | 18.6× | 1.0× | 4.0× | 1.4× | −33.0% | 0.0× | 1.86 |
Forecasts
Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 0.65 AUD · Analysts' mean
- EPS, year to Jun 2027
- 0.021 · 1 analyst
- Revenue, year to Jun 2027
- 75.6M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Troy Lamb | Chief Financial Officer and Company Secretary |
| David Burton | Executive Chairman |
| David Lawson | Executive Finance Director |
| Warwick Freeman | Chief Technology Officer |
Board
| Director | Role |
|---|---|
| David Burton | Executive Chairman |
| Rod North | Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Dec 31, 2025 | Feb 26, 2026 · Before open | −3.8% |
| Quarter to Jun 30, 2025 | Sep 30, 2025 | −1.8% |
| Q2 2025 | Feb 28, 2025 | −12.3% |
| Q2 2023 | Feb 28, 2023 · After close | −11.1% |
| Q4 2022 | Sep 30, 2022 · After close | −4.1% |
| Q2 2022 | Feb 22, 2022 | +7.3% |
| Q4 2021 | Aug 30, 2021 | +2.5% |
| Q2 2021 | Feb 24, 2021 | −2.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2026) | Investor deck | 18 slides | Nov 11, 2026 |
| Investor Presentation (November 2026) | Investor deck | 18 slides | November 2026 |
| Shareholder Meeting (October 2026) | Shareholder meeting | 29 slides | Oct 29, 2026 |
| Shareholder Meeting (October 2026) | Shareholder meeting | 29 slides | Oct 29, 2026 |
| FY2026 Earnings Presentation | Earnings | 27 slides | Sep 30, 2026 |
| Investor Presentation (March 2026) | Investor deck | 22 slides | Mar 25, 2026 |
| Investor Presentation (October 2025) | Investor deck | 20 slides | Sep 30, 2025 |
| Investor Presentation (March 2025) | Investor deck | 23 slides | Mar 6, 2025 |
| Investor Presentation (June 2024) | Investor deck | 28 slides | Jun 6, 2024 |
| Bell Potter Healthcare Conference 2023 | Conference | 22 slides | Nov 16, 2023 |
Show 50 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (October 2021) | Shareholder meeting | 26 slides | Oct 28, 2021 |
| Investor Presentation (October 2021) | Investor deck | 24 slides | October 2021 |
| Investor Presentation (August 2021) | Investor deck | 18 slides | Aug 10, 2021 |
| Investor Presentation (March 2021) | Investor deck | 24 slides | March 2021 |
| Shareholder Meeting (November 2019) | Shareholder meeting | 25 slides | November 2019 |
| Investor Presentation (October 2019) | Investor deck | 22 slides | October 2019 |
| Investor Presentation (April 2019) | Investor deck | 26 slides | April 2019 |
| Shareholder Meeting (October 2018) | Shareholder meeting | 25 slides | Oct 25, 2018 |
| Investor Presentation (October 2018) | Investor deck | 22 slides | October 2018 |
| Investor Presentation (March 2018) | Investor deck | 26 slides | Mar 21, 2018 |
| Shareholder Meeting (October 2017) | Shareholder meeting | 26 slides | October 2017 |
| Investor Presentation (September 2017) | Investor deck | 22 slides | Sep 5, 2017 |
| Investor Presentation (February 2017) | Investor deck | 24 slides | Feb 28, 2017 |
| Shareholder Meeting (October 2016) | Shareholder meeting | 23 slides | Oct 27, 2016 |
| Non-Deal Roadshow (September 2016) | Roadshow | 18 slides | September 2016 |
| Non-Deal Roadshow (June 2016) | Roadshow | 18 slides | June 2016 |
| Investor Presentation (April 2016) | Investor deck | 18 slides | Apr 1, 2016 |
| Investor Presentation (February 2016) | Investor deck | 32 slides | Feb 11, 2016 |
| Shareholder Meeting (October 2015) | Shareholder meeting | 34 slides | October 2015 |
| Investor Presentation (September 2015) | Investor deck | 31 slides | Aug 26, 2015 |
| Investor Presentation (May 2015) | Investor deck | 29 slides | May 1, 2015 |
| Investor Presentation (May 2015) | Investor deck | 32 slides | Apr 29, 2015 |
| Shareholder Meeting (September 2014) | Shareholder meeting | 30 slides | September 2014 |
| Investor Presentation (March 2014) | Investor deck | 36 slides | Mar 27, 2014 |
| Shareholder Meeting (October 2013) | Shareholder meeting | 29 slides | Oct 31, 2013 |
| Shareholder Meeting (October 2011) | Shareholder meeting | 19 slides | October 2011 |
| H1 FY2011 Earnings Presentation | Earnings | 12 slides | Feb 28, 2011 |
| Non-Deal Roadshow (December 2009) | Roadshow | 20 slides | Dec 10, 2009 |
| Investor Presentation (December 2009) | Investor deck | 18 slides | December 2009 |
| Shareholder Meeting (October 2009) | Shareholder meeting | 39 slides | October 2009 |
| Shareholder Meeting (November 2008) | Shareholder meeting | 29 slides | November 2008 |
| H1 FY2008 Earnings Presentation | Earnings | 29 slides | Feb 27, 2008 |
| H1 FY2008 Earnings Presentation | Earnings | 29 slides | Feb 26, 2008 |
| FY2007 Earnings Presentation | Earnings | 27 slides | Aug 30, 2007 |
| Shareholder Meeting (2007) | Shareholder meeting | 34 slides | 2007 |
| Shareholder Meeting (November 2006) | Shareholder meeting | 31 slides | Nov 28, 2006 |
| Shareholder Meeting (October 2005) | Shareholder meeting | 25 slides | Oct 28, 2005 |
| Shareholder Meeting (October 2005) | Shareholder meeting | 25 slides | October 2005 |
| Investor Presentation (April 2005) | Investor deck | 22 slides | April 2005 |
| H1 FY2005 Earnings Presentation | Earnings | 16 slides | Feb 18, 2005 |
This page holds 50 of 57 decks. Open Decks
Financials
Annual, in AUD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51.0M | 49.7M | 42.4M | 37.8M | 35.7M | 35.1M | 41.5M | 37.0M | 34.4M | 37.5M |
| Cost of revenue | 20.1M | 23.7M | 20.8M | 18.4M | 16.6M | 17.1M | 16.7M | 15.8M | 15.4M | 17.6M |
| Gross profit | 31.0M | 26.1M | 21.6M | 19.3M | 19.2M | 18.0M | 24.8M | 21.2M | 19.1M | 19.9M |
| Research and development | 1.13M | 5.74M | 5.46M | 4.06M | 4.39M | 3.84M | 5.32M | 5.11M | 5.88M | 5.75M |
| Selling, general and administrative | 17.4M | 7.08M | 6.41M | 5.64M | 6.12M | 5.93M | 6.01M | 5.48M | 5.64M | 5.26M |
| Operating income | 714.0K | -812.0K | -3.53M | 137.0K | 398.0K | -756.0K | 4.54M | 2.58M | 1.42M | 3.21M |
| Depreciation and amortization | 2.25M | 1.57M | 1.01M | 1.21M | 1.46M | 1.66M | 428.0K | 482.0K | 1.28M | 1.64M |
| EBITDA | 2.96M | 758.0K | -2.52M | 1.35M | 1.85M | 908.0K | 4.97M | 3.06M | 2.70M | 4.85M |
| Interest expense | 1.28M | 739.0K | 652.0K | 401.0K | 330.0K | 420.0K | 261.0K | 207.0K | 312.0K | 405.0K |
| Income before tax | -593.0K | 480.0K | -6.72M | 1.70M | 776.0K | -7.50M | 5.09M | 3.49M | 1.11M | 2.81M |
| Income tax | 679.0K | 818.0K | -597.0K | 341.0K | -222.0K | -1.67M | 1.07M | 703.0K | -199.0K | -467.0K |
| Net income | -1.27M | -338.0K | -6.12M | 1.36M | 998.0K | -5.84M | 4.02M | 2.78M | 1.30M | 3.27M |
| Earnings per share, basic | -0.01 | -0.00 | -0.03 | 0.01 | 0.01 | -0.03 | 0.02 | 0.02 | 0.01 | 0.02 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.69M | 1.89M | 3.80M | 7.29M | 6.77M | 6.41M | 4.60M | 3.91M | 4.10M | 3.07M |
| Short-term investments | 0 | 0 | ||||||||
| Receivables | 14.9M | 11.1M | 15.0M | 16.5M | 15.5M | 13.6M | 16.0M | 16.2M | 12.9M | 11.7M |
| Inventory | 14.7M | 13.2M | 10.7M | 9.71M | 9.68M | 8.83M | 7.80M | 7.56M | 7.42M | 6.51M |
| Current assets | 35.2M | 26.2M | 29.5M | 33.5M | 31.9M | 28.9M | 30.2M | 29.8M | 25.3M | 22.4M |
| Property, plant and equipment | 1.78M | 2.95M | 3.62M | 1.21M | 1.71M | 3.08M | 1.65M | 666.0K | 718.0K | 832.0K |
| Total assets | 54.4M | 40.4M | 41.2M | 41.7M | 38.5M | 35.5M | 38.7M | 34.7M | 29.2M | 26.1M |
| Accounts payable | 11.7M | 4.37M | 5.26M | 4.74M | 4.45M | 2.93M | 3.10M | 3.91M | 2.94M | 3.02M |
| Current liabilities | 32.1M | 21.3M | 21.2M | 17.5M | 15.4M | 12.4M | 10.2M | 11.3M | 8.94M | 11.2M |
| Long-term debt | 0 | 205.0K | 379.0K | 593.0K | 11.0K | 23.0K | 38.0K | 8.00K | 11.0K | |
| Total debt | 13.9M | 8.58M | 9.47M | 6.55M | 5.82M | 4.80M | 1.59M | 1.89M | 715.0K | 2.58M |
| Total liabilities | 32.6M | 22.1M | 22.9M | 18.1M | 16.4M | 13.7M | 11.3M | 11.5M | 9.18M | 11.5M |
| Shareholders' equity | 21.8M | 18.2M | 18.3M | 23.6M | 22.2M | 21.8M | 27.3M | 23.2M | 20.1M | 14.6M |
| Shares outstanding | 181.7M | 177.2M | 177.2M | 177.2M | 177.2M | 177.2M | 177.2M | 177.2M | 177.2M | 168.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 681.0K | 2.00M | 49.0K | 3.29M | 1.32M | 5.38M | 5.14M | 559.0K | 864.0K | 2.23M |
| Capital spending | -214.0K | -2.99M | -4.41M | -2.98M | -1.55M | -4.23M | -1.31M | -208.0K | -148.0K | -304.0K |
| Free cash flow | 467.0K | -986.0K | -4.36M | 302.0K | -230.0K | 1.15M | 3.82M | 351.0K | 716.0K | 1.93M |
| Cash from investing | -7.37M | -2.99M | -4.41M | -2.98M | -1.55M | -4.23M | -4.29M | -2.02M | -1.29M | -1.54M |
| Cash from financing | 6.10M | -1.49M | -1.00M | 1.61M | -179.0K | 448.0K | 149.0K | 1.15M | 1.96M | -199.0K |
| Dividends paid | 0 | 0 | ||||||||
| Share buybacks | 0 | 4.23M | 150.0K | |||||||
| Change in cash | -556.0K | -2.57M | -3.50M | 2.15M | -874.0K | 1.81M | 1.17M | -198.0K | 1.48M | 569.0K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Investor Update Nov-26 | Nov 10, 2026 | Results | ASX |
| Appointment of Strategic Advisor | Nov 5, 2026 | Management or board change | ASX |
| Appointment of Chief Financial Officer & Company Secretary | Oct 29, 2026 | Management or board change | ASX |
| Results of Meeting | Oct 29, 2026 | Meeting outcome | ASX |
| Chair's Address to Shareholders | Oct 28, 2026 | Other filings | ASX |
| Appendix 4G | Oct 1, 2026 | Other filings | ASX |
| Corporate Governance Statement | Oct 1, 2026 | Other filings | ASX |
| Proxy Form | Oct 1, 2026 | Proxy form | ASX |
| Notice of Annual General Meeting | Oct 1, 2026 | Meeting notice | ASX |
| Investor Presentation | Sep 29, 2026 | Results | ASX |
All 136 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Annual Report to shareholders | Sep 29, 2026 | Annual report | ASX |
| Business Update | Aug 24, 2026 | Results | ASX |
| Preliminary Final Report | Aug 24, 2026 | Results | ASX |
| FY26 Update | Jul 5, 2026 | Results | ASX |
| Business Update April 2026 | Apr 20, 2026 | Operations update | ASX |
| Half Yearly Report and Accounts | Feb 24, 2026 | Interim report | ASX |
| 6th & New MEG Order | Jan 28, 2026 | Other filings | ASX |
| H1 FY25 Update - Record Sales | Jan 21, 2026 | Results | ASX |
| 5th & New MEG Order | Nov 9, 2025 | Operations update | ASX |
| $2.15 Million Capital Raise for Somfit D | Oct 14, 2025 | Other filings | ASX |
| Trading Halt | Oct 12, 2025 | Trading halt or suspension | ASX |
| Somfit D FDA | Sep 3, 2025 | Operations update | ASX |
| Business Update FY26 | Aug 27, 2025 | Results | ASX |
| Preliminary Final Report | Aug 27, 2025 | Results | ASX |
| Business Update Asia - $24m agreements signed | Jul 28, 2025 | Operations update | ASX |
| FY25 Business Update - Record sales orders taken | Jul 13, 2025 | Results | ASX |
| New MEG order | Mar 20, 2025 | Operations update | ASX |
| Half Year Report and Accounts | Feb 28, 2025 | Interim report | ASX |
| New 5 year Somfit contract with Philips | Jan 21, 2025 | Operations update | ASX |
| H1 FY25 Update - Record sales orders taken | Jan 14, 2025 | Other filings | ASX |
| H1 FY25 Record Sales Orders taken | Dec 22, 2024 | Other filings | ASX |
| Capital Raise | Dec 4, 2024 | Financing | ASX |
| Business Update | Oct 16, 2024 | Operations update | ASX |
| FY2024 full year update | Sep 5, 2024 | Other filings | ASX |
| Europe Trading Update | Aug 5, 2024 | Operations update | ASX |
| Business Update FY24 | Jul 15, 2024 | Results | ASX |
| Placement | Jul 4, 2024 | Financing | ASX |
| FY24 Business Update | May 22, 2024 | Operations update | ASX |
| Business Update December 31 | Jan 10, 2024 | Results | ASX |
| $9.3m MEG sales to China | Dec 11, 2023 | Operations update | ASX |
| Pause in Trading | Dec 10, 2023 | Trading halt or suspension | ASX |
| Somfit FDA cleared for USA market | Dec 3, 2023 | Other filings | ASX |
| Business Update - 30 June 2023 | Jul 5, 2023 | Operations update | ASX |
| Half year update | Feb 28, 2023 | Other filings | ASX |
| Half Year Accounts | Feb 28, 2023 | Interim report | ASX |
| Business Update Dec 22 | Jan 24, 2023 | Operations update | ASX |
| Chairmans Address to Shareholders | Oct 27, 2022 | Other filings | ASX |
| Business Update 30 June 2022 | Aug 17, 2022 | Operations update | ASX |
| Share buy back announcement | Aug 11, 2022 | Other filings | ASX |
| 30 June 22 Business Update | Jul 13, 2022 | Operations update | ASX |
| Pre June 30 Update | May 27, 2022 | Other filings | ASX |
| Business Update 31 Dec 21 | Feb 25, 2022 | Operations update | ASX |
| Business Update - Dec 21 | Jan 11, 2022 | Operations update | ASX |
| New MEG Sale | Jan 11, 2022 | Other filings | ASX |
| Dec 8 Supplementary Release | Dec 16, 2021 | Other filings | ASX |
| Somfit Vic Gov Release | Dec 7, 2021 | Other filings | ASX |
| Business Update - June 21 | Aug 26, 2021 | Operations update | ASX |
| Business Update - 30 June 2021 | Jul 18, 2021 | Operations update | ASX |
| Business Update Dec 2020 | Jan 19, 2021 | Operations update | ASX |
| 30 June 20 Business Update | Aug 30, 2020 | Operations update | ASX |
| 30 June 20 Preliminary Update | Jul 10, 2020 | Other filings | ASX |
| Coronavirus | Mar 23, 2020 | Other filings | ASX |
| Half Year Update | Mar 1, 2020 | Other filings | ASX |
| MEG FDA Approval | Feb 16, 2020 | Other filings | ASX |
| Dec 31 Business Update | Jan 12, 2020 | Operations update | ASX |
| Record Revenues and Profit Up | Sep 1, 2019 | Other filings | ASX |
| Response to ASX Price Query | Jul 24, 2019 | Explanation request | ASX |
| CMP MEG Update | May 8, 2019 | Other filings | ASX |
| Major US contract win | Mar 20, 2019 | Material contract | ASX |
| China JV Update | Oct 24, 2018 | Other filings | ASX |
| Change of Registry Address: Automic P/L - Sydney Office | Sep 28, 2018 | Other filings | ASX |
| Revenues up 8%, NPAT up 133% | Aug 29, 2018 | Other filings | ASX |
| Business Up-date - June 18 | Jun 27, 2018 | Other filings | ASX |
| Fukuda $3.6m Japan EEG Distribution Contract | Jun 27, 2018 | Other filings | ASX |
| Somfit Strategic China Deal | May 30, 2018 | Other filings | ASX |
| Trading Halt Request | May 28, 2018 | Trading halt or suspension | ASX |
| $15m in new distribution contracts | May 24, 2018 | Other filings | ASX |
| DWL China Update | May 1, 2018 | Other filings | ASX |
| H1 2018 Investor Presentation | Mar 20, 2018 | Other filings | ASX |
| S&P DJ Indices Announces March Quarterly Rebalance | Mar 8, 2018 | Other filings | ASX |
| Business Update H1 FY18 | Feb 25, 2018 | Operations update | ASX |
| Major European Contract Win | Sep 20, 2017 | Material contract | ASX |
| Business Performance FY17 | Aug 28, 2017 | Other filings | ASX |
| July 2017 Business Update | Jul 6, 2017 | Operations update | ASX |
| Compumedics wins major MEG Contract | Jun 19, 2017 | Other filings | ASX |
| $3m in new orders from China | May 17, 2017 | Other filings | ASX |
| $2.3 China Commitment for DWL | Mar 2, 2017 | Other filings | ASX |
| Corporate Presentation March 2017 | Feb 27, 2017 | Other filings | ASX |
| AGM Presentation Oct 2016 | Oct 27, 2016 | Other filings | ASX |
| Successful Capital Raise | Sep 23, 2016 | Other filings | ASX |
| Business Update - 30 June 2016 | Aug 26, 2016 | Operations update | ASX |
| New $3m EEG Contract in China | Jul 26, 2016 | Other filings | ASX |
| FY16 Guidance update, continuing growth in FY17 | Jul 17, 2016 | Guidance | ASX |
| DWL Update & MEG Appointment | Jun 7, 2016 | Other filings | ASX |
| Record Sales Week | Apr 13, 2016 | Other filings | ASX |
| $600k Perth Childrens Hospital | Mar 30, 2016 | Other filings | ASX |
| Appendix 4E Annual | Mar 30, 2016 | Results | ASX |
| German contract win based on GRAEL HD-PSG system | Mar 30, 2016 | Material contract | ASX |
| Compumedics achieves world first brain monitoring | Mar 30, 2016 | Other filings | ASX |
| China Update - new $1m contract won | Mar 30, 2016 | Other filings | ASX |
| Chairman`s Address to Shareholders | Mar 30, 2016 | Other filings | ASX |
| $900k boost to China business | Mar 30, 2016 | Other filings | ASX |
| Full Year Accounts - Appendix 4E | Mar 30, 2016 | Results | ASX |
| Compumedics Chinese Distributor Deal | Mar 30, 2016 | Other filings | ASX |
| New USD5m eHealth Contract | Mar 30, 2016 | Other filings | ASX |
| Business Update - June 2104 | Mar 30, 2016 | Operations update | ASX |
| DWL secures lucrative Brazil deal | Mar 30, 2016 | Other filings | ASX |
| $2.0m China Contracts | Mar 30, 2016 | Other filings | ASX |
| Half Year Report & Accounts | Mar 30, 2016 | Interim report | ASX |
| New Neuro business and FY2013 up-date | Mar 30, 2016 | Other filings | ASX |
| Further Funding and New Business Update | Mar 30, 2016 | Operations update | ASX |
| Funding Milestone Achieved | Mar 30, 2016 | Other filings | ASX |
| Business Update March 2013 | Mar 30, 2016 | Operations update | ASX |
| Appendix 4D Interim accounts 31 Dec 15 | Feb 24, 2016 | Interim report | ASX |
| MEG Major Deal US Trade Mission | Feb 21, 2016 | Other filings | ASX |
| Preliminary half year guidance - on track | Feb 11, 2016 | Guidance | ASX |
| US contract win | Feb 10, 2016 | Material contract | ASX |
| Additional $1m China Sleep Contract | Feb 10, 2016 | Other filings | ASX |
| $2m Korean contract | Feb 10, 2016 | Other filings | ASX |
| Preliminary 30 June 2015 Guidance | Feb 10, 2016 | Guidance | ASX |
| Record Ultrasound Contracts in Germany | Feb 10, 2016 | Other filings | ASX |
| $7.5m China Sleep Contract | Feb 10, 2016 | Other filings | ASX |
| US Neurology Contract win - $1m | Feb 10, 2016 | Material contract | ASX |
| Broker Presentation May 2015 | Feb 10, 2016 | Other filings | ASX |
| New $2.2m China Neurology Contract | Feb 10, 2016 | Other filings | ASX |
| DWL New Patent Granted | Feb 10, 2016 | Other filings | ASX |
| DWL Secures Deal | Feb 10, 2016 | Other filings | ASX |
| New EFIC Facility in place | Feb 10, 2016 | Other filings | ASX |
| eHealth USD4.1m contracts signed | Feb 10, 2016 | Other filings | ASX |
| Additional US Purchasing Contract Win | Feb 10, 2016 | Material contract | ASX |
| Major contract win in the US | Feb 10, 2016 | Material contract | ASX |
| Key European Contract Win | Feb 10, 2016 | Material contract | ASX |
| Major Contract Milestone | Feb 10, 2016 | Other filings | ASX |
| Major EEG contract win | Feb 10, 2016 | Material contract | ASX |
| Banking refinance completed | Feb 10, 2016 | Other filings | ASX |
| US FDA Approves Major Product Release | Feb 10, 2016 | Other filings | ASX |
Cap table
Built by 6ix from Compumedics Limited’s releases
- Common shares
- 199,761,754
- Fully diluted
- 199,761,754
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 199,761,754 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 199,761,754 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Burton | Executive Chairman · Since at least May 15, 2025 |
| David Lawson | Executive Finance Director · Since at least May 15, 2025 |
| Rod North | Non-Executive Director · Since at least Nov 7, 2026 |
| Troy Lamb | Chief Financial Officer and Company Secretary · Since at least Oct 29, 2026 |
| Warwick Freeman | Chief Technology Officer · Since at least Nov 7, 2026 |
Log in to ask 6ix AI your own questions about Compumedics Limited.